Citadel Advisors’s Diebold Nixdorf DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-300
Closed -$13.1K 12970
2025
Q1
$13.1K Buy
+300
New +$13.1K ﹤0.01% 13416
2024
Q4
Sell
-4,800
Closed -$214K 14651
2024
Q3
$214K Buy
+4,800
New +$199K ﹤0.01% 10003

Other funds holding DBD

Citadel Advisors's DBD Position: Q2 2026 in Review

Citadel Advisors reduced its Diebold Nixdorf (DBD) stake by 98% in Q2 2026, selling an estimated $8.87M and leaving 2,717 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #11730.

Citadel Advisors first reported a position in DBD in Q3 2023 and has held it in 10 quarters since. The position peaked at $8.53M in Q1 2026. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.

  • Citadel Advisors held 2,717 shares of Diebold Nixdorf worth $231K as of Q2 2026.
  • Citadel Advisors sold 110,354 Diebold Nixdorf shares in Q2 2026, an estimated $8.87M.
  • Diebold Nixdorf made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11730 holding.
  • Citadel Advisors first reported a position in Diebold Nixdorf in Q3 2023 and has held it in 10 quarters since.
  • Citadel Advisors's Diebold Nixdorf position peaked at $8.53M in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.